Astellas Pharma launches once-daily oral tacrolimus formulation in US Pharmaceutical Business Review The new product is indicated for the prophylaxis of organ rejection in patients receiving a kidney transplant used with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction. Astellas Pharma US president James Robinson ... ASTELLAS PHARMA INC : ASTAGRAF XLTM (tacrolimus extended-release ... Astellas' Astagraf XL Launched in U.S. - Analyst Blog BIZ BRIEF: Astellas announces availability of Astagraf XL capsules in US |
